Literature DB >> 7831528

Ductal carcinoma in situ: a proposal for a new classification.

R Holland1, J L Peterse, R R Millis, V Eusebi, D Faverly, M J van de Vijver, B Zafrani.   

Abstract

Details of a proposed new classification for ductal carcinoma in situ (DCIS) are presented. This is based, primarily, on cytonuclear differentiation and, secondarily, on architectural differentiation (cellular polarisation). Three categories are defined. First is poorly differentiated DCIS composed of cells with very pleomorphic, irregularly spaced nuclei, with coarse, clumped chromatin, prominent nucleoli, and frequent mitoses. Architectural differentiation is absent or minimal. The growth pattern is solid or pseudo-cribriform and -micropapillary (without cellular polarisation). Necrosis is usually present. Calcification, when present, is amorphous. Second, at the other end of the spectrum is well-differentiated DCIS, composed of cells with monomorphic, regularly spaced nuclei containing fine chromatin, inconspicuous nucleoli, and few mitoses. The cells show pronounced polarisation with orientation of their apical border towards intercellular spaces usually resulting in cribriform, micropapillary and clinging patterns, although a solid pattern of well-differentiated DCIS also occurs. Necrosis is uncommon. Calcifications, when present, are usually psammomatous. The third category, intermediately differentiated DCIS, is composed of cells showing some pleomorphism but not so marked as in the poorly differentiated group. There is, however, always evidence of polarization around intercellular spaces, although this is not so pronounced as in the well-differentiated group. These two criteria, cytonuclear differentiation and architectural differentiation, have been found to be more consistent throughout a DCIS lesion than previously employed criteria of architectural pattern or the presence or absence of necrosis.

Entities:  

Mesh:

Year:  1994        PMID: 7831528

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  98 in total

1.  Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.

Authors:  A G Douglas-Jones; J M Morgan; M A Appleton; R L Attanoos; A Caslin; C S Champ; M Cotter; N S Dallimore; A Dawson; R W Fortt; A P Griffiths; M Hughes; P A Kitching; C O'Brien; A M Rashid; D Stock; A Verghese; D W Williams; N W Williams; S Williams
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

2.  Gene expression profiles of human breast cancer progression.

Authors:  Xiao-Jun Ma; Ranelle Salunga; J Todd Tuggle; Justin Gaudet; Edward Enright; Philip McQuary; Terry Payette; Maria Pistone; Kimberly Stecker; Brian M Zhang; Yi-Xiong Zhou; Heike Varnholt; Barbara Smith; Michelle Gadd; Erica Chatfield; Jessica Kessler; Thomas M Baer; Mark G Erlander; Dennis C Sgroi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-24       Impact factor: 11.205

3.  Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.

Authors:  E Dublin; A Hanby; N K Patel; R Liebman; D Barnes
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

5.  Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast.

Authors:  A G Douglas-Jones; J Logan; J M Morgan; R Johnson; R Williams
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

6.  Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.

Authors:  J D Otten; J A van Dijck; P G Peer; H Straatman; A L Verbeek; M Mravunac; J H Hendriks; R Holland
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

7.  Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast.

Authors:  V Londero; C Zuiani; A Furlan; J Nori; M Bazzocchi
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

8.  Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.

Authors:  Kalliopi P Siziopikou; Stewart J Anderson; Melody A Cobleigh; Thomas B Julian; Douglas W Arthur; Ping Zheng; Eleftherios P Mamounas; Eduardo R Pajon; Robert J Behrens; Janice F Eakle; Nick C Leasure; James N Atkins; Jonathan A Polikoff; Thomas E Seay; Worta J McCaskill-Stevens; Rachel Rabinovitch; Joseph P Costantino; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2013-11-08       Impact factor: 4.872

Review 9.  Preinvasive breast cancer.

Authors:  Dennis C Sgroi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

10.  E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast.

Authors:  S K Gupta; A G Douglas-Jones; B Jasani; J M Morgan; M Pignatelli; R E Mansel
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.